CompletedNot Applicable

Impact Study of Cholera Vaccination in Endemic Areas - Seroprevalence

Democratic Republic of the Congo7,000 participantsStarted 2021-09-20

Plain-language summary

This project aims to fill this essential knowledge gap by assessing the impact of oral cholera vaccine mass campaigns in 2 sites (urban and rural) in DRC, described in this protocol. The evidence generated from this project will be key to develop future strategies regarding cholera vaccine use in endemic settings, including places with higher burden in terms of cholera mortality

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Living in the randomly-selected households in targeted area AND
✓. Randomly selected among household members. Inclusions will be limited to 1 participant per household, except for one survey AND
✓. Giving his/her consent (or assent for children 13 to 17 years old) to participate in the study

What they're measuring

To better characterize cholera immunization in the population of cholera hotspot in Africa and assess the impact of a large vaccination campaign reaching high coverage

Timeframe: 2 years

Trial details

NCT IDNCT05829772

SponsorEpicentre

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-03-31

View on ClinicalTrials.gov More Cholera trials